Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001383906 | SCV001583232 | pathogenic | not provided | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV002307741 | SCV002602794 | likely pathogenic | Achromatopsia 3 | 2022-02-01 | criteria provided, single submitter | clinical testing | NM_019098.4(CNGB3):c.886_890del5(T296Yfs*14) is expected to be pathogenic in the context of CNGB3-related achromatopsia. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in CNGB3, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |